Mechanisms of LouDan LiFei granule attenuate inflammatory injury in AECOPD:A network pharmacology and experimental validation
This research highlights the potential for LDLF in the treatment of AECOPD and enhances our understanding of its pathogenic and therapeutic mechanisms.
Authors
- Zengtao Sun (ORCID: https://orcid.org/0000-0002-3017-8198)
- Jingxia Wang (ORCID: https://orcid.org/0000-0003-4780-4367)
- Qingyuan Wu (ORCID: https://orcid.org/0000-0003-0877-4185)
- Z C Wang
- Linshui Zhou (ORCID: https://orcid.org/0000-0001-5520-9563)
- Jianfeng Wang (ORCID: https://orcid.org/0000-0001-8311-0894)
- Tingzhen Xu
- Jing Guo (ORCID: https://orcid.org/0000-0002-8503-3746)
- Xuemin Gao (ORCID: https://orcid.org/0000-0002-5905-2556)
- Si-Jia Guo
- Xin Lv
- An Chi Guo (ORCID: https://orcid.org/0009-0003-7256-1317)
Institutions
- Zhejiang Chinese Medical University (CN)
- Tianjin University of Traditional Chinese Medicine (CN)
- Beijing University of Chinese Medicine (CN)
- Second Hospital of Tianjin Medical University (CN)
- Beijing Hospital of Traditional Chinese Medicine (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Phytomedicine
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1016/j.phymed.2025.156719
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00